AMLODIPINE\TELMISARTAN: 490 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
490
Total FAERS Reports
22 (4.5%)
Deaths Reported
228
Hospitalizations
490
As Primary/Secondary Suspect
83
Life-Threatening
8
Disabilities
Active Ingredient: AMLODIPINE BESYLATE\TELMISARTAN ·
First Report: 20110608 · Latest Report: 20250315
What Are the Most Common AMLODIPINE\TELMISARTAN Side Effects?
#1 Most Reported
Hypotension
70 reports (14.3%)
#2 Most Reported
Toxicity to various agents
66 reports (13.5%)
#3 Most Reported
Pain
60 reports (12.2%)
All AMLODIPINE\TELMISARTAN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypotension | 70 | 14.3% | 0 | 67 |
| Toxicity to various agents | 66 | 13.5% | 0 | 65 |
| Balance disorder | 60 | 12.2% | 0 | 59 |
| Depressed level of consciousness | 60 | 12.2% | 0 | 59 |
| Pain | 60 | 12.2% | 0 | 57 |
| Constipation | 59 | 12.0% | 0 | 57 |
| Blood calcium decreased | 57 | 11.6% | 0 | 57 |
| Fall | 57 | 11.6% | 0 | 57 |
| Sedation complication | 56 | 11.4% | 0 | 56 |
| Cognitive disorder | 55 | 11.2% | 0 | 55 |
| Creatinine renal clearance decreased | 55 | 11.2% | 0 | 55 |
| Mobility decreased | 55 | 11.2% | 0 | 55 |
| Orthostatic hypotension | 55 | 11.2% | 0 | 55 |
| Sedation | 55 | 11.2% | 0 | 55 |
| Febrile neutropenia | 40 | 8.2% | 0 | 0 |
| Blood pressure increased | 37 | 7.6% | 0 | 6 |
| Dyspnoea | 37 | 7.6% | 0 | 35 |
| Off label use | 36 | 7.4% | 1 | 32 |
| Drug interaction | 33 | 6.7% | 0 | 33 |
| Overdose | 33 | 6.7% | 0 | 33 |
Who Reports AMLODIPINE\TELMISARTAN Side Effects? Age & Gender Data
Gender: 51.9% female, 48.1% male. Average age: 67.3 years. Most reports from: CA. View detailed demographics →
Is AMLODIPINE\TELMISARTAN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 3 | 0 | 1 |
| 2012 | 6 | 1 | 5 |
| 2013 | 1 | 0 | 1 |
| 2014 | 15 | 2 | 5 |
| 2015 | 33 | 1 | 17 |
| 2016 | 30 | 1 | 20 |
| 2017 | 16 | 0 | 10 |
| 2018 | 20 | 2 | 7 |
| 2019 | 24 | 1 | 18 |
| 2020 | 19 | 1 | 8 |
| 2021 | 9 | 0 | 2 |
| 2022 | 6 | 0 | 1 |
| 2023 | 12 | 0 | 10 |
| 2024 | 10 | 1 | 3 |
| 2025 | 1 | 0 | 1 |
What Is AMLODIPINE\TELMISARTAN Used For?
| Indication | Reports |
|---|---|
| Hypertension | 251 |
| Product used for unknown indication | 191 |
| Angina pectoris | 30 |
| Coronary artery disease | 29 |
| Constipation | 20 |
| Blood pressure abnormal | 7 |
| Chest pain | 5 |
AMLODIPINE\TELMISARTAN vs Alternatives: Which Is Safer?
AMLODIPINE\TELMISARTAN vs AMLODIPINE\VALSARTAN
AMLODIPINE\TELMISARTAN vs AMMONIUM
AMLODIPINE\TELMISARTAN vs AMNESTEEM
AMLODIPINE\TELMISARTAN vs AMOXAPINE
AMLODIPINE\TELMISARTAN vs AMOXICILLIN
AMLODIPINE\TELMISARTAN vs AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE
AMLODIPINE\TELMISARTAN vs AMOXICILLIN\CLARITHROMYCIN\LANSOPRAZOLE
AMLODIPINE\TELMISARTAN vs AMOXICILLIN\CLAVULANATE
AMLODIPINE\TELMISARTAN vs AMOXICILLIN\CLAVULANIC ACID
AMLODIPINE\TELMISARTAN vs AMOXICILLIN\OMEPRAZOLE\RIFABUTIN
Official FDA Label for AMLODIPINE\TELMISARTAN
Official prescribing information from the FDA-approved drug label.